Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Aim. To clarify the mechanisms of the effect of osteoprotegerin (OPG) and sclerostin on vascular calcification and the state of the cardiovascular system in chronic kidney disease (CKD). Materials and methods. A total of 110 patients aged 18 to 65 years with CKD stages 35D were examined. OPG, scl...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2022-08-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/109609/83868 |
| _version_ | 1798041040017424384 |
|---|---|
| author | Fatima U. Dzgoeva Oleg V. Remizov Victoria Kh. Botcieva Victoria G. Goloeva Nina G. Malakhova Zarina R. Ikoeva |
| author_facet | Fatima U. Dzgoeva Oleg V. Remizov Victoria Kh. Botcieva Victoria G. Goloeva Nina G. Malakhova Zarina R. Ikoeva |
| author_sort | Fatima U. Dzgoeva |
| collection | DOAJ |
| description | Aim. To clarify the mechanisms of the effect of osteoprotegerin (OPG) and sclerostin on vascular calcification and the state of the cardiovascular system in chronic kidney disease (CKD).
Materials and methods. A total of 110 patients aged 18 to 65 years with CKD stages 35D were examined. OPG, sclerostin, intact parathyroid hormone, and serum troponin I were determined using the commercial "Enzyme-linked Immunosorbent Assay Kit for Sclerostin" from Cloude-Clone Corp. (USA) by enzyme-linked immunosorbent assay.
Results. An increase in sclerostin and OPG levels was revealed, which significantly correlated with a decrease in glomerular filtration rate, as well as an increase in left ventricle myocardial mass index and peak systolic blood flow in the aortic arch.
Conclusion. Changes in the regulation of bone-mineral metabolism, in which the proteins inhibitors of bone metabolism, OPG and sclerostin, as well as the interactive interaction between the vascular and skeletal systems, play a decisive role in the development of lesions of the cardiovascular system caused by vascular calcification in CKD. |
| first_indexed | 2024-04-11T22:15:57Z |
| format | Article |
| id | doaj.art-f8157f23a2514e8e99a065130ed7f255 |
| institution | Directory Open Access Journal |
| issn | 0040-3660 2309-5342 |
| language | Russian |
| last_indexed | 2024-04-11T22:15:57Z |
| publishDate | 2022-08-01 |
| publisher | "Consilium Medicum" Publishing house |
| record_format | Article |
| series | Терапевтический архив |
| spelling | doaj.art-f8157f23a2514e8e99a065130ed7f2552022-12-22T04:00:23Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422022-08-0194673173710.26442/00403660.2022.06.20156278128Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5Fatima U. Dzgoeva0https://orcid.org/0000-0002-7314-9063Oleg V. Remizov1https://orcid.org/0000-0003-4175-5365Victoria Kh. Botcieva2https://orcid.org/0000-0002-0539-8666Victoria G. Goloeva3https://orcid.org/0000-0001-5310-889XNina G. Malakhova4https://orcid.org/0000-0001-5564-9948Zarina R. Ikoeva5https://orcid.org/0000-0002-4183-2335North Ossetian State Medical AcademyNorth Ossetian State Medical AcademyNorth Ossetian State Medical AcademyNorth Ossetian State Medical AcademyNorth Ossetian State Medical AcademyNorth Ossetian State Medical AcademyAim. To clarify the mechanisms of the effect of osteoprotegerin (OPG) and sclerostin on vascular calcification and the state of the cardiovascular system in chronic kidney disease (CKD). Materials and methods. A total of 110 patients aged 18 to 65 years with CKD stages 35D were examined. OPG, sclerostin, intact parathyroid hormone, and serum troponin I were determined using the commercial "Enzyme-linked Immunosorbent Assay Kit for Sclerostin" from Cloude-Clone Corp. (USA) by enzyme-linked immunosorbent assay. Results. An increase in sclerostin and OPG levels was revealed, which significantly correlated with a decrease in glomerular filtration rate, as well as an increase in left ventricle myocardial mass index and peak systolic blood flow in the aortic arch. Conclusion. Changes in the regulation of bone-mineral metabolism, in which the proteins inhibitors of bone metabolism, OPG and sclerostin, as well as the interactive interaction between the vascular and skeletal systems, play a decisive role in the development of lesions of the cardiovascular system caused by vascular calcification in CKD.https://ter-arkhiv.ru/0040-3660/article/viewFile/109609/83868chronic kidney diseaseosteoprotegerinsclerostincardiovascular calcificationremodeling of the heart and aorta |
| spellingShingle | Fatima U. Dzgoeva Oleg V. Remizov Victoria Kh. Botcieva Victoria G. Goloeva Nina G. Malakhova Zarina R. Ikoeva Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 Терапевтический архив chronic kidney disease osteoprotegerin sclerostin cardiovascular calcification remodeling of the heart and aorta |
| title | Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
| title_full | Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
| title_fullStr | Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
| title_full_unstemmed | Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
| title_short | Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
| title_sort | clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3 5 |
| topic | chronic kidney disease osteoprotegerin sclerostin cardiovascular calcification remodeling of the heart and aorta |
| url | https://ter-arkhiv.ru/0040-3660/article/viewFile/109609/83868 |
| work_keys_str_mv | AT fatimaudzgoeva clinicalsignificanceofserumlevelsofosteoproteherinandsclerostininassessmentofvascularcalcificationinchronickidneydiseasestage35 AT olegvremizov clinicalsignificanceofserumlevelsofosteoproteherinandsclerostininassessmentofvascularcalcificationinchronickidneydiseasestage35 AT victoriakhbotcieva clinicalsignificanceofserumlevelsofosteoproteherinandsclerostininassessmentofvascularcalcificationinchronickidneydiseasestage35 AT victoriaggoloeva clinicalsignificanceofserumlevelsofosteoproteherinandsclerostininassessmentofvascularcalcificationinchronickidneydiseasestage35 AT ninagmalakhova clinicalsignificanceofserumlevelsofosteoproteherinandsclerostininassessmentofvascularcalcificationinchronickidneydiseasestage35 AT zarinarikoeva clinicalsignificanceofserumlevelsofosteoproteherinandsclerostininassessmentofvascularcalcificationinchronickidneydiseasestage35 |